KeyMed Biosciences Inc
HKEX:2162
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
KeyMed Biosciences Inc
HKEX:2162
|
CN |
|
Keppel REIT
SGX:K71U
|
SG |
|
H
|
Henry Schein Inc
XMUN:HS2
|
US |
|
A
|
Apple Inc
DUS:APC
|
US |
|
TAT Technologies Ltd
NASDAQ:TATT
|
IL |
|
Flex Ltd
NASDAQ:FLEX
|
SG |
|
Diebold Nixdorf Inc
NYSE:DBD
|
US |
|
Ultragenyx Pharmaceutical Inc
NASDAQ:RARE
|
US |
|
Seatrium Limited
SGX:5E2
|
SG |
Intrinsic Value
The intrinsic value for KeyMed Biosciences Inc (2162) under the Base Case is hidden HKD. Compared with the current market price of 61.35 HKD, the stock appears hidden .
KeyMed Biosciences Inc looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether KeyMed Biosciences Inc usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for KeyMed Biosciences Inc.
The intrinsic value for KeyMed Biosciences Inc (2162) under the Base Case is hidden HKD.
Compared with the current market price of 61.35 HKD, the stock appears hidden.